Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-16-013956
Filing Date
2016-12-07
Accepted
2016-12-07 11:37:16
Documents
37
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K bkit_10k.htm 10-K 294135
2 CERTIFICATION bkit_ex31.htm EX-31 7762
3 CERTIFICATION bkit_ex32.htm EX-32 2673
10 bkit_10kimg1.jpg GRAPHIC 7662
  Complete submission text file 0001477932-16-013956.txt   1152112

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bkit-20160831.xml EX-101.INS 116203
5 XBRL TAXONOMY EXTENSION SCHEMA bkit-20160831.xsd EX-101.SCH 15096
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bkit-20160831_cal.xml EX-101.CAL 22499
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bkit-20160831_def.xml EX-101.DEF 25579
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bkit-20160831_lab.xml EX-101.LAB 89040
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bkit-20160831_pre.xml EX-101.PRE 76515
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 (646) 453-4912
Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)

EIN.: 460780380 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-55022 | Film No.: 162038099
SIC: 7200 Services-Personal Services